J.W. Cole Advisors, Inc. Vbi Vaccines Inc Transaction History

J.W. Cole Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$0.73 - $23.4 $219 - $7,020	-300 Reduced 0.91%	32,800 $23,000
Q2 2022 Jul 27, 2022	SELL	$0.66 - $1.81 $13,200 - $36,200	-20,000 Reduced 37.66%	33,100 $27,000
Q1 2022 Jun 10, 2022	SELL	$1.27 - $2.47 $44,256 - $86,074	-34,848 Reduced 39.62%	53,100 $88,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $18,856 - $36,674	14,848 Added 20.31%	87,948 $53,000
Q4 2021 Jan 25, 2022	BUY	$2.21 - $3.22 $4,420 - $6,440	2,000 Added 2.81%	73,100 $171,000
Q3 2021 Oct 26, 2021	BUY	$2.8 - $3.72 $2,240 - $2,976	800 Added 1.14%	71,100 $221,000
Q2 2021 Aug 06, 2021	BUY	$2.61 - $4.17 $78,263 - $125,041	29,986 Added 74.38%	70,300 $236,000
Q1 2021 Apr 28, 2021	SELL	$2.91 - $4.32 $89,377 - $132,684	-30,714 Reduced 43.24%	40,314 $125,000
Q4 2020 Feb 12, 2021	BUY	$2.15 - $3.5 $152,710 - $248,598	71,028 New	71,028 $195,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.